HEMOLYTIC DISEASE OF THE NEWBORN
Abstract
Introduction/Aim: Haemolytic disease of the newborn is haemolytic anaemia that occurs as a consequence of mismatched blood of the parents, that is, the mismatch of blood elements between the mother and fetus in the ABO or Rh system. The aim of this study is to report a case of haemolytic disease of the newborn which occurred as a result of ABO incompatibility.
Case report: Indirect hyperbilirubinemia was registered in a female newborn in the 18th hour of life. The blood group of the newborn was A Rh (D) positive, the direct Coombs test was positive and anti-A antibodies were detected in baby’s blood. This case was successfully managed with phototherapy and simple red blood cells transfusion without the need for exchange transfusion.
Conclusion: ABO incompatibility can be a major problem in the prenatal, perinatal or neonatal periods. Special attention should be paid to pregnant women whose children from previous pregnancies had hyperbilirubinemia or whose pregnancies were ended in miscarriage.
References
1. Dufour DR, Monoghan WP. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases. Am J Clin Pathol 1980; 73(3):369-73. doi: 10.1093/ajcp/73.3.369.
2. Lazarus C, Avchen R. Neonatal hyperbilirubinemia management: a model for change. J Perinatol 2009; 29:S58–S60. doi: 10.1038/jp.2008.217
3. Kaur D, Sidana P, Mandhan G,Kanodia K. Oblivious of the Yellow World – A Newborn’s Telltale: ABO Hemolytic Disease of Newborn. Glob J Transfus Med 2019; 4(1):87-89. doi: 10.4103/GJTM.GJTM_45_18
4. Hall V, Avulakunta ID. Hemolytic diseases of the newborn. [Updated 2021 Aug 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK557423/
5. Trainor B, Tubman R. The emerging pattern of hydrops fetalis--incidence, aetiology and management. Ulster Med J 2006;75(3):185-186.
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1):297-316. doi: 10.1542/peds.114.1.297
7. Fasano RM. Hemolytic disease of the fetus and newborn in the molecular era. Semin Fetal Neonatal Med 2016;21(1):28-34. doi:10.1016/j.siny.2015.10.006
8. Chen JY, Ling UP. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Zhonghua yi xue za zhi = Chinese Medical Journal; Free China ed. 1994; 53(1):13-18. PMID: 8173995.
9. Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007;
92(2):F83-8. doi: 10.1136/adc.2005.076794.
10. Adewuyi JO, Gwanzura C. Racial difference between white and black Zimbabweans in the haemolytic activity of A, B, O antibodies. Afr J Med Med Sci 2001; 30(1-2):71- 74.
11. McDonncell M, Hannam S, Devane SP. Hydrops fetalis due to ABO incompatibility. Arch Dis Child Fetal Neonatal Ed 1998; 78(3):F220-221. doi: 10.1136/fn.78.3.f220
12. Malekasgar AM. ABO blood group prevalence in spontaneously repeated abortion. Turk J Haematol 2004; 21(4):181-7.
13. Stiller RJ, Herzlinger R, Siegel S, Whetham JC. Fetalascites associated with ABO incompatibility: case reportand review of the literature. Am J Obstet Gynecol 1996; 175: 1371-1372. doi: 10.1016/s0002-378(96)70057-1
14. Hyperbilirubinemia: Unconjugated. In: Gomella T, Eyal FG, Bany-Mohammed F. eds. Gomella's Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs, 8e. McGraw Hill; 2020. Available at: https://accesspediatrics.mhmedical.com/content.aspx?bookid=2762§ionid=234453147(cited June 11, 2022. )